⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Matt Kazan, former Senate Finance advisor, returns to Avalere Health as Senior Vice President, Policy, and Laura Housman elevates to Chief Public Health Officer USA - English USA - English
prnewswire.com
EXAS
NVS
Chemical Synthesis Peptide Drugs Market Set to Reach USD 4.82 Billion by 2034, Growing at a 6.54% CAGR Driven by Automation and Green Chemistry Advances
globenewswire.com
LLY
NVS
MRK
CytoAgents Appoints Dr. Johannes Wolff as Chief Medical Officer and Michael Howell as Chief Scientific Officer
businesswire.com
RPRX
ABBV
NVS
ZURA
INCY
AZN
Vertigo Drugs Market Outlook Report 2026-2034 - Landscape Shift Towards Targeted Drug Regimens Over Blanket Suppression, Emphasizing Early Rehab and Non-Sedating Prophylactics - ResearchAndMarkets.com
businesswire.com
ABT
SNY
PFE
GSK
NVS
Diabetic Neuropathy Market Report: Trends, Forecast and Competitive Analysis to 2031 - APAC Leads Industry Growth as Demand for Pain Management Soars - ResearchAndMarkets.com
businesswire.com
PFE
JNJ
LLY
GSK
NVS
Novartis breaks ground on flagship manufacturing hub in North Carolina
globenewswire.com
NVS
Kyowa Kirin annonce la nomination proposée d'Abdul Mullick au poste de président et CEO, tandis que l'ancien CEO Masashi Miyamoto restera président du conseil
businesswire.com
SNY
NVS
Acute Lymphocytic Leukemia Market: Analysis and Forecast, 2025-2035
globenewswire.com
BMY
NVS
PFE
GILD
MRK
Biopharmaceutical Contract Manufacturing Market to Surpass US$ 100 Billion by 2031
globenewswire.com
NVS
PFE
CTSH
Tristan Imbert co-opted as Independent Director
globenewswire.com
SNY
NVS